🔎 Trials Near Me

Utama › Kanser Metastatik › Ohio › Cleveland

Kajian klinikal Kanser Metastatik di Cleveland, OH

30 kajian untuk Kanser Metastatik sedang mencari peserta di lokasi dalam dan sekitar Cleveland (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

Mengambil pesertaFasa 1/2
  • Avenzo Therapeutics Recruiting Site, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT07193511

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Mengambil pesertaFasa 2
  • Case Western Reserve University, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi jauh
  • UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 mi jauh
Semua umur · Semua jantina · Dikemas kini 5 Okt 2026 · NCT05564377

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Mengambil pesertaFasa 1
  • University Hospitals Cleveland Medical Center, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Mengambil pesertaFasa 1/2
  • The Cleveland Clinic Taussig Cancer Center, Cleveland
Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04585750

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Mengambil pesertaFasa 1
  • University Hospitals Cleveland Medical Center, Cleveland
  • Cleveland Clinic, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06234605

A Study of ASP3082 in Adults With Advanced Solid Tumors

Mengambil pesertaFasa 1
  • Case Western, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT05382559

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Mengambil pesertaFasa 2/3
  • University Hospitals Cleveland Medical Center, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT06943755

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Mengambil pesertaFasa 3
  • University Hospitals Cleveland Medical Center, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07222800

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Mengambil pesertaFasa 3
  • University Hospitals Cleveland Medical Center, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07222566

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Mengambil pesertaFasa 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • Fairview Hospital, Cleveland
  • Cleveland Clinic, Cleveland
  • dan 1 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07213804

SLV-154 Treatment of Advanced Cancers

Mengambil pesertaFasa 1
  • University Hospitals Cleveland Medical Center, Cleveland
Umur 12 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06771219

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Mengambil pesertaFasa 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • Fairview Hospital, Cleveland
  • Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07174336

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • University Hospitals Cleveland Medical Center, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06566079

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Mengambil pesertaFasa 3
  • Cleveland Clinic, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06072612

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Mengambil pesertaFasa 1
  • Cleveland Clinic, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT04913285

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Mengambil pesertaFasa 1
  • Cleveland Clinic, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07029399

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
  • Cleveland Clinic, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT05919264

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Mengambil pesertaFasa 3
  • Research Site, Cleveland
  • Research Site, Cleveland
Umur 18 ke atas · Wanita · Dikemas kini 29 Jul 2026 · NCT07044336

A Study of ASP1002 in Adults for Treatment of Solid Tumors

Mengambil pesertaFasa 1
  • University Hospitals of Cleveland, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jul 2026 · NCT05719558

REMASTer: REcurrent Brain Metastases After SRS Trial

Mengambil peserta
  • Cleveland Clinic, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Jun 2026 · NCT05124912

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1
  • Research Site, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Jun 2026 · NCT07284186

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Mengambil pesertaFasa 1
  • University Hospitals - UH Cleveland Medical Center, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Mei 2026 · NCT07094204

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

Mengambil pesertaFasa 2/3
  • Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Umur 18 ke atas · Lelaki · Dikemas kini 8 Apr 2026 · NCT04787744

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • Cleveland Clinic, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Feb 2026 · NCT07030257

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

Mengambil pesertaFasa 3
  • Cleveland Clinic, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Feb 2026 · NCT06127407

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi jauh
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

Mengambil pesertaFasa 1
  • University Hospitals Cleveland Medical Center, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2025 · NCT05808634

A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer

Mengambil pesertaFasa 1
  • Case Western Reserve University, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Ogo 2024 · NCT06548672

Kajian Kanser Metastatik di bandar lain

Kajian lain di Cleveland

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.